pindolol has been researched along with enalapril in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (23.81) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Flügge, G; Nazarali, AJ; Pinto, JE; Saavedra, JM; Torda, T; Viglione, PN | 1 |
| Armstrong, VW; Buhr-Schinner, H; Kandt, M; Scheler, F; Schoel, G; Schrader, J; Warneke, G | 1 |
| Buhr-Schinner, H; Haupt, A; Kandt, M; Scheler, F; Schoel, G; Schrader, J; Schuster, S; Warneke, G | 1 |
| Buhr-Schinner, H; Haupt, A; Kandt, M; Scheler, F; Schoel, G; Schrader, J; Warneke, G | 1 |
| Allan, G; Cambridge, D; Whiting, MV | 1 |
| Vidt, DG | 1 |
| Lowenthal, DT | 1 |
| Lüscher, TF; Waeber, B | 1 |
| Fitscha, P; Magometschnigg, D; Meisner, W | 1 |
| Forster, C; Larosa, G; Naik, GO | 1 |
| Fitscha, P; Meisner, W | 1 |
| Magometschnigg, D | 1 |
| Desfontis, JC; Gogny, M; Le Coz, O; Mallem, MY; Reculeau, O | 1 |
3 review(s) available for pindolol and enalapril
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Advances in the medical management of renovascular hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Atenolol; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propanolamines; Propranolol; Renal Artery Obstruction; Renin-Angiotensin System; Saralasin; Timolol | 1984 |
6 trial(s) available for pindolol and enalapril
| Article | Year |
|---|---|
Comparison of the antihypertensive efficiency of nitrendipine, metoprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Enalapril; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Monitoring, Physiologic; Nitrendipine; Pindolol | 1990 |
[24-hour blood pressure behavior in patients with untreated and treated hypertension in comparison with normotensive patients].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitors; Circadian Rhythm; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Middle Aged; Nitrendipine; Pindolol; Randomized Controlled Trials as Topic | 1989 |
[Ambulatory continuous 24-hour blood pressure monitoring in the diagnosis and therapy of arterial hypertension and modification by the antihypertensive agents enalapril, metoprolol, mepindolol and nitrendipine].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Circadian Rhythm; Clinical Trials as Topic; Enalapril; Humans; Hypertension; Metoprolol; Microcomputers; Monitoring, Physiologic; Nitrendipine; Pindolol | 1988 |
Efficacy and safety of various combination therapies based on a calcium antagonist in essential hypertension: results of a placebo-controlled randomized trial.
Topics: Adrenergic beta-Antagonists; Aged; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Isradipine; Male; Metolazone; Middle Aged; Pindolol | 1993 |
A multicenter study using causal readings, self-recordings, and ambulatory blood pressure monitoring to assess isradipine effects. AMICUS Study Group.
Topics: Adult; Aged; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Drug Therapy, Combination; Enalapril; Female; Humans; Isradipine; Male; Middle Aged; Pindolol; Self Care | 1994 |
Isradipine in the treatment of mild-to-moderate hypertension. The Austrian Multicenter Isradipine cum Spirapril Study (AMICUS).
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Determination; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol; Treatment Outcome | 1993 |
12 other study(ies) available for pindolol and enalapril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Increased beta 2-adrenoceptors in the superior cervical ganglia of genetically hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Autoradiography; Binding Sites; Binding, Competitive; Enalapril; Ganglia, Sympathetic; Hypertension; Imidazoles; Iodocyanopindolol; Pindolol; Propanolamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta | 1991 |
Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.
Topics: Adrenergic beta-Antagonists; Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Dogs; Enalapril; Female; Heart; Indoles; Isoproterenol; Male; Pindolol; Propanolamines; Propranolol; Renal Circulation | 1988 |
New drugs for hypertension.
Topics: Antihypertensive Agents; Bumetanide; Diltiazem; Dipeptides; Enalapril; Guanabenz; Guanidines; Humans; Indapamide; Labetalol; Nifedipine; Pindolol; Verapamil | 1984 |
Myocardial beta-adrenoceptors in pacing-induced heart failure: regulation by enalapril?
Topics: Angiotensin II; Animals; Cardiac Output, Low; Cardiac Pacing, Artificial; Dogs; Enalapril; Heart Ventricles; Iodine Radioisotopes; Iodocyanopindolol; Kinetics; Male; Membranes; Myocardium; Norepinephrine; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta; Renin | 1994 |
Indication for antihypertensive treatment: superiority of ambulatory vs casual blood pressure measurement.
Topics: Adult; Aged; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Determination; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Isradipine; Male; Middle Aged; Pindolol | 1994 |
Low-affinity state beta1-adrenoceptor-induced vasodilation in SHR.
Topics: Adrenergic beta-1 Receptor Agonists; Alprenolol; Animals; Aorta; Blood Pressure; Dose-Response Relationship, Drug; Enalapril; Losartan; Male; Muscle Relaxation; Pindolol; Propanolamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta-1; Vasodilation | 2005 |